Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Skylight Health Group Inc SLHGF

Skylight Health Group Inc. is a Canada-based healthcare services and technology company. The Company operates a Florida-based primary care health network comprised of physical practices providing a range of services from primary care, sub-specialty, allied health and laboratory/diagnostic testing. The Company is focused on helping small and independent practices shift from a traditional fee-for-service (FFS) model to value-based care (VBC) through tools, including proprietary technology, data analytics and infrastructure. The Company has two segments related to its medical services and software and corporate businesses, which also align with the two countries in which it operates, namely, United States and Canada. It provides a range of healthcare services, including primary and urgent care, sub-specialists, allied health and wellness, and laboratory/diagnostic testing.


GREY:SLHGF - Post by User

Post by waves1on Nov 16, 2022 5:38pm
246 Views
Post# 35104978

Impressive Q3 results from SLHG!

Impressive Q3 results from SLHG!

Third quarter 2022 financial results from SLHG:

  • Increased revenue to $20.8M compared to $16.1M in previous quarter w/ 152% growth year over year
  • Net loss from continuing operations reduced by 16% from previous quarter to $4.3M, compared to $5.2M
  • Adjusted EBITDA loss reduced by 27% from previous quarter
  • Established new Medicare Advantage plans in Florida with expected 2023 participation in ACO Reach with traditional Medicare members moving to full-risk
  • Reduced annual cost base by over $10M w/ further operational improvements by year end
  • Closed non-brokered private placement for $2.35M

 

This quarter was a major step for SLHG in achieving its 2022 goals, with increased top line while reducing costs & improving adjusted EBITDA.

F
urther improvement in adjusted EBITDA are expected by SLHG for Q4 w/ aim toward adjusted EBITDA break-even by 2022

 

Notably, SLHG accelerated its journey to VBC by 3 years with acquisition of NMD & partnership with CHS.


Going forward, SLHG is strongly positioned for organic growth, expected to primarily be driven by value-based-care contribution in Medicare and Medicare Advantage growth. 

<< Previous
Bullboard Posts
Next >>